comparemela.com

Page 8 - Matthew Wolfson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Electromedical Technologies Secures Funding for Product Expansion

– Company on track for late 2021 FDA filing SCOTTSDALE, Ariz., Feb. 23, 2021 (GLOBE NEWSWIRE) Electromedical Technologies, Inc. (OTCQB: EMED) (the “Company”), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that it has secured a $1 million investment by a fund managed by Yorkville Advisors Global, LP to complete prototype production of its WellnessPlus POD, a critical step in the Company’s product development and expansion plans. Further details of the financing can be found in Electromedical Technologies’ recent 8-K filing. The Company’s prototype is slated to be completed later this year and will be used in a 510(k) medical device submission with the FDA later this year. The 

Electromedical s Annual Cyber Sale of Flagship Pain Relief Electrotherapy Device Set to Drive Year-End Revenue

Share: - Early indications suggest solid demand for highly effective pain relief device - Current cyber special offering $300 discount runs through December 23 rd - With $4.2 million in inventory, Electromedical setting stage for major sales ahead SCOTTSDALE, Ariz., Dec. 15, 2020 (GLOBE NEWSWIRE) Electromedical Technologies, Inc. (OTCQB:EMED) (the Company ), a pioneer in the development and manufacturing of bioelectronic devices, including the FDA cleared WellnessPro+, is pleased to announce that its annual product special offer is generating solid demand and interest, which is typical of this holiday season cyber campaign. The current cyber sale includes a $300 discount off of the flagship WellnessPro+ price and continues through December 23, 2020.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.